Questions?????

How do Rapid Mist and Oralyn fit into the new business model?

Are there milestone payments in the agreement with AE, Keytruda, and Merck?

Is the buyout of AE a possibility that has been discussed?

Are there milestone payments in the agreement with Shengzen?

Will there be spin-offs in addition to AE?

Will the spin off of AE enable it to be uplisted before Generex?

What is the time frame for uplisting Generex?

What is the greatest hurdle to the uplisting?